Bd Biosciences Systems And Reagents Inc is categorized under Medical Research in San Jose, CA and active since 1991.
Bd Biosciences Systems And Reagents Inc was established in 1991, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Chris Demiris at the company’s single location by writing to 2350 Qume Drive, San Jose, California CA 95131 or by phoning (408) 432-9475. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bd Biosciences Systems And Reagents Inc |
Contact Person: | Chris Demiris |
Address: | 2350 Qume Drive, San Jose, California 95131 |
Phone Number: | (408) 432-9475 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1991 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Bd Biosciences Systems And Reagents Inc was started in 1991 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chris Demiris for inquiries that concern Bd Biosciences Systems And Reagents Inc by calling the company number (408) 432-9475, as your correspondence is most welcome. Additionally, the physical location of the single location of Bd Biosciences Systems And Reagents Inc can be found at the coordinates 37.397295,-121.888359 as well as the street address 2350 Qume Drive in San Jose, California 95131.
For its online presence, you may visit Bd Biosciences Systems And Reagents Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.